Avicanna Secures New U.S. Patent for Innovative Topical Cannabinoid Skin Treatment
Avicanna (TSX: AVCN, OTCQX: AVCNF) has secured a new patent from the United States Patent and Trademark Office that covers its topical cannabinoid formulation aimed
